Agios Pharmaceuticals (AGIO) Accumulated Depreciation (2012 - 2016)

Agios Pharmaceuticals has reported Accumulated Depreciation for 5 years, with the latest figure at $13.4 million in Q4 2016.

• For the quarter ending Q4 2016, Accumulated Depreciation rose 74.48% year-over-year to $13.4 million; the trailing twelve-month figure through Dec 2016 stood at $13.4 million (up 74.48% YoY), and the FY2016 full-year result was $13.4 million, up 74.48% from the prior year.
• Accumulated Depreciation for Q4 2016 stood at $13.4 million, up from $7.7 million in the prior quarter.
• The five-year high for Accumulated Depreciation was $13.4 million in Q4 2016, with the low at $2.8 million in Q4 2012.
• Historically, Accumulated Depreciation has averaged $6.7 million across 5 years, with a median of $5.6 million in 2014.
• Annual changes were most pronounced in 2014 — Accumulated Depreciation surged 32.62% — and 2016, when it jumped 74.48%.
• Agios Pharmaceuticals' Accumulated Depreciation stood at $2.8 million in 2012, then jumped by 52.34% to $4.2 million in 2013, then surged by 32.62% to $5.6 million in 2014, then surged by 37.89% to $7.7 million in 2015, then jumped by 74.48% to $13.4 million in 2016.
• The last three Accumulated Depreciation figures came in at $13.4 million (Q4 2016), $7.7 million (Q4 2015), and $5.6 million (Q4 2014), per Business Quant data.